CD163 versus CD68 in tumor associated macrophages of classical hodgkin lymphoma
<p>Abstract</p> <p>Classical Hodgkin lymphoma (CHL) is a B-cell lymphoproliferative disorder with a relatively good prognosis. A small but significant percentage of patients, however, will respond poorly to therapy. A recent gene expression profiling study has identified a macropha...
Main Authors: | Harris Jonathan A, Jain Salvia, Ren Qinghu, Zarineh Alirezah, Liu Cynthia, Ibrahim Sherif |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2012-01-01
|
Series: | Diagnostic Pathology |
Online Access: | http://www.diagnosticpathology.org/content/7/1/12 |
Similar Items
-
Prognostic significance of CD163- and CD68-expressing macrophages in nodular sclerosis Hodgkin lymphoma
by: E. A. Perfilova, et al.
Published: (2022-01-01) -
Relationship of Tumor-Associated Macrophage Population Detected by CD68 PG-M1, CD68 KP1, and CD163 with Latent EBV Infection and Prognosis in Classical Hodgkin Lymphoma
by: Hanife Seda MAVILI, et al.
Published: (2021-05-01) -
The role of CD68+ macrophage in classical Hodgkin lymphoma patients from Egypt
by: Osama Mohamed, et al.
Published: (2020-02-01) -
High Counts of CD68+ and CD163+ Macrophages in Mantle Cell Lymphoma Are Associated With Inferior Prognosis
by: Philippa Li, et al.
Published: (2021-08-01) -
The clinical significance of the CD163+ and CD68+ macrophages in patients with hepatocellular carcinoma.
by: Ling-Qun Kong, et al.
Published: (2013-01-01)